Key indicators: single-crystal X-ray study; T = 290 K; mean (C-C) = 0.004 Å; R factor = 0.041; wR factor = 0.114; data-to-parameter ratio = 13.6.
In the title compound, C 15 H 11 BrN 4 O 2 S, the tetrazole ring makes dihedral angles of 45.97 (10) and 75.41 (1) , respectively, with the benzoyl and bromobenzene rings while the dihedral angle between the benzene rings is 73.77 (1) . In the crystal, molecules are linked through O-HÁ Á Á N and C-HÁ Á Á O hydrogen bonds, giving infinite chains in both the [110] and [110] directions. These chains are further connected by CBrÁ Á Á and C-OÁ Á Á interactions and also by -stacking between tetrazole rings [centroid-centroid distance = 3.312 (1) Å ], generating a three-dimensional network.
Related literature
For details of the ZINC database, see: Irwin et al. (2012) . For biological properties of tetrazoles, see: Kees et al. (1989) ; Nolte et al. (1998) ; Mafud et al. (2013) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ).
Cg1 and Cg2 are the centroids of the N1-N4/C8 tetrazole ring and the C10-C15 benzene ring, respectively. 
Data collection: COLLECT (Nonius, 1999 ); cell refinement: SCALEPACK (Otwinowski & Minor, 1997); data reduction: DENZO (Otwinowski & Minor, 1997) and SCALEPACK; program(s) used to solve structure: SIR92 (Altomare et al., 1994 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: WinGX (Farrugia, 2012) . Otwinowski, Z. & Minor, W. (1997 The title acid is a screening molecule available in the ZINC database (Irwin et al., 2012) among the 'drugs-now′ subset.
This molecule has been identified as a PPAR gamma ligand candidate in a virtual screening study. The Peroxisome
Proliferator-Activated Receptor, isoform gamma, is a transcription factor that regulates the expression of genes involved in glucose and lipid metabolism (Nolte et al., 1998) . Our group recently described the crystal structure of a similar compound, evaluated as a PPARgligand in a competition assay (Mafud et al., 2013) . Since tetrazoles are already known to have glucose lowering effects in vivo (Kees et al., 1989) , in this virtual screening we chose some different representative molecules to evaluate the affinities and the extent of receptor activation. Here, we report the crystal structure of the title compound.
The dihedral angles between the tetrazole and the benzoyl and the bromo benzene rings are 45.97 (10)° and 75.41 (1)° respectively, while between the two benzene rings is 73.77 (1)°. The crystal packing is established through interactions of three types (Table 1) :
The first one are intermolecular hydrogen bonds: O2-H1···N4(ii) and C9-H9···O1(i), with symmetry codes: (i)1+ x,
The second one are C-X···π interactions: C1-O1 ··· Cg1(iii), 3.619 (2) Å and C11-Br1 ··· Cg2(iv), 3.581 (2) Å, where
Cg1 and Cg2 are the centroids of the {N1, N2, N3, N4, C8} and {C10, C11, C12, C13, C14, C15} rings, respectively, with symmetry codes:
And the last type is π-π stacking between centrosymmetric tetrazole neighbour rings (centroid-centroid distance=3.312 (1) Å )
A colourless single-crystal of the title compound was selected from the sample as supplied (Pharmeks Ltd.) without recrystallization.
Refinement
The hydroxyl H atom was located in a difference Fourier map and refined with U iso (H) = 1.5Ueq(O). The C-bound H atoms were included in calculated positions and treated as riding atoms: C-H = 0.93 and 0.97 Å, for CH and CH 2 respectively, with U iso (H) = 1.2Ueq(C).
Computing details
Data collection: COLLECT (Nonius, 1999) (Farrugia, 2012) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: WinGX (Farrugia, 
Figure 1
Perspective view of the molecular structure of the title compound, with displacement ellipsoids drawn at the 50% probability level.
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Figure 2
A view along the a axis of the crystal packing of the title compound.
4-{5-[(2-Bromobenzyl)sulfanyl]-1H-tetrazol-1-yl}benzoic acid
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